Answers are grounded in this paper and cite their sources.
Review evaluates the potential of crop-derived nanomaterials for cancer research, indicating their promise and challenges.
Industrial crops and agro-residues provide chemically diverse feedstocks for green nanomaterial development, but their value for cancer research depends on more than renewable origin. This review evaluates industrial crop-derived nanomaterials through a feedstock design-functional matching-translational challenge framework. Feedstock design is considered in terms of cellulose-rich biomass for cellulose nanocrystals and cellulose nanofibers, lignin-rich residues for nanolignin and redox-active carriers, phytochemical-rich tissues for plant-mediated metal and metal-oxide nanoparticles, carbon-rich residues for carbon dots and carbon-based hybrids, lipid-rich crops for lipid carriers, and edible or medicinal plant tissues for plant-derived vesicle-like nanoparticles. This review emphasizes that these material classes are not interchangeable anticancer systems. Nanocellulose and nanolignin are most suitable as drug-delivery matrices, hydrogels, stabilizing scaffolds, and redox-modulating carriers. Plant-mediated Ag, Au, ZnO, CuO, Fe-oxide, and Se nanoparticles are more closely associated with reactive oxygen species generation, apoptosis induction, imaging, magnetic response, or photothermal function. Biomass-derived carbon materials are better aligned with fluorescence imaging, photothermal therapy, photodynamic therapy, and theranostics, whereas lipid-based carriers and plant-derived vesicle-like nanoparticles are more relevant for cargo delivery, membrane interaction, and immunomodulation. Current evidence remains dominated by two-dimensional cancer-cell assays, which often overestimate anticancer performance because they do not reproduce serum protein interactions, tumor penetration barriers, heterogeneous enhanced permeability and retention effects, mononuclear phagocyte clearance, biodistribution, or long-term toxicity. Future advances in the field require standardized feedstock reporting, controlled synthesis, rigorous physicochemical characterization, reproducibility testing, phytochemical- and protein-corona analysis, function-matched cancer models, safety and clearance studies, and scalable production. This review presents industrial crop-derived nanomaterials as promising but technically demanding platforms for cancer applications, highlighting a rational matching between feedstock chemistry, nanoscale function, biological model, and translational feasibility.
No takes yet. Share an insight, caveat, or question.
Ma et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: